<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glaucoma</journal-id><journal-title-group><journal-title xml:lang="ru">Национальный журнал Глаукома</journal-title><trans-title-group xml:lang="en"><trans-title>National Journal glaucoma</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-4104</issn><issn pub-type="epub">2311-6862</issn><publisher><publisher-name>Federal State Budgetary Institution of Science “Krasnov Research Institute of Eye Diseases”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.53432/2078-4104-2025-24-3-3-10</article-id><article-id custom-type="elpub" pub-id-type="custom">glaucoma-580</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Особенности ведения пациента с глаукомой и сопутствующей миопией</article-title><trans-title-group xml:lang="en"><trans-title>Features of management of glaucoma patients with myopia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9606-0566</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куроедов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuroyedov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, заведующий кафедрой офтальмологии, начальник офтальмологического центра (с дневным стационаром)</p><p>117997, Москва, ул. Островитянова, 1</p><p>107014, Москва, ул. Б. Оленья, 8А</p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor, Head of the Academic Department of Ophthalmology, Head of Ophthalmology Сenter </p><p>1 Ostrovityanov St., Moscow, 117997 </p><p>8A Bolshaya Olenya St., Moscow, 107014 </p></bio><email xlink:type="simple">akuroyedov@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2348-4880</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Булах</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bulakh</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-офтальмолог, ассистент кафедры оториноларингологии и офтальмологии </p><p>153021, Иваново, ул. Рабфаковская, 30 </p><p>153012, Иваново, просп. Шереметьевский, 8</p></bio><bio xml:lang="en"><p>ophthalmologist, Assistant Professor at the Academic Department of Otorhinolaryngology and Ophthalmology</p><p>30b Rabfakovskaya St., Ivanovo, 153021</p><p>8 Sheremetevskiy Ave., Ivanovo, 153012</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7276-5753</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Городничий</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorodnichii</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-офтальмолог </p><p>107014, Москва, ул. Б. Оленья, 8А</p></bio><bio xml:lang="en"><p>ophthalmologist </p><p>8A Bolshaya Olenya St., Moscow, 107014 </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4583-6050</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селезнев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Seleznev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доцент кафедры оториноларингологии и офтальмологии </p><p>153012, Иваново, просп. Шереметьевский, 8</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), Associate Professor at the Academic Department of Otorhinolaryngology and Ophthalmology</p><p>8 Sheremetevskiy Ave., Ivanovo, 153012</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5893-7371</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гапонько</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gaponko</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., заведующий дневным стационаром, доцент кафедры офтальмологии </p><p>107014, Москва, ул. Б. Оленья, 8А</p><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), Associate Professor at the Academic Department of Ophthalmology, Head of the Day Patient Department at the Ophthalmology Center</p><p>1 Ostrovityanov St., Moscow, 117997 </p><p>8A Bolshaya Olenya St., Moscow, 107014 </p></bio><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО РНИМУ им. Н.И. Пирогова МЗ РФ (Пироговский Университет) ; ФКУ ЦВКГ им. П.В. Мандрыка МО РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University ; Mandryka Central Clinical Military Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ООО Медицинский центр «Ивастрамед» ; ФГБОУ ВО Ивановский ГМУ МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>OOO Medicinskiy centr Ivastramed ; Ivanovo State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФКУ ЦВКГ им. П.В. Мандрыка МО РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mandryka Central Clinical Military Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБОУ ВО Ивановский ГМУ МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ivanovo State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФКУ ЦВКГ им. П.В. Мандрыка МО РФ ; ФГАОУ ВО РНИМУ им. Н.И. Пирогова МЗ РФ (Пироговский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University ; Mandryka Central Clinical Military Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>13</day><month>09</month><year>2025</year></pub-date><volume>24</volume><issue>3</issue><fpage>3</fpage><lpage>10</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Куроедов А.В., Булах И.А., Городничий В.В., Селезнев А.В., Гапонько О.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Куроедов А.В., Булах И.А., Городничий В.В., Селезнев А.В., Гапонько О.В.</copyright-holder><copyright-holder xml:lang="en">Kuroyedov A.V., Bulakh I.A., Gorodnichii V.V., Seleznev A.V., Gaponko O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.glaucomajournal.ru/jour/article/view/580">https://www.glaucomajournal.ru/jour/article/view/580</self-uri><abstract><p>ЦЕЛЬ. Изучение мнения врачей-офтальмологов относительно тактики ведения пациентов с сочетанием миопии и глаукомы.МЕТОДЫ. Многоцентровое научно-аналитическое описательное выборочное исследование выполнено группой «Научный авангард» Российского глаукомного общества в июле – сентябре 2024 года на основании онлайн-анкетирования врачей-офтальмологов РФ с разным стажем и/или опытом, работающих в учреждениях разной формы собственности. Разработанная анкета имела защищенное расположение в Интернете. В исследовании участвовали 302 врача-офтальмолога. Преобладали клиницисты (97%), работающие в поликлиническом звене (89%) государственных учреждений (85%) со стажем 6–15 лет (48%) без квалификационной категории (44%), проживающие в больших городах (41%) и городах-миллионниках (44%).РЕЗУЛЬТАТЫ. По мнению опрошенных, пациенты с сочетанной глаукомой и миопией встречаются на приеме еженедельно (48%). Преобладали миопия средней степени (58%), молодой возраст (70%), продвинутые стадии глаукомы (55%), умеренно повышенный офтальмотонус (b) (71%), глаукома низкого давления (58%), характеризующиеся быстрым прогрессированием (52%), отсутствием жалоб (72%) и наличием сопутствующей кардиоваскулярной патологии (44%). Тонометрия выполняется в основном по Маклакову (47%). Врачи испытывают сложности при диагностике глаукомы у таких пациентов (51%), предпочитают более низкие значения офтальмотонуса (83%), который сложнее достигнуть (53%); стараются избегать назначения М-холиномиметиков (33%) и бета-адреноблокаторов (27%), и чаще прибегать к применению комбинированной терапии (75%). Респонденты полагают, что пациенты нуждаются в дополнительном нейропротекторном лечении (97%). Бо́ льшая часть считает, что селективная лазерная трабекулопластика менее эффективна (44%) и такие пациенты чаще оперируются (51%; при этом менее успешно — 53%) и с бо́ льшим числом осложнений (60%).ЗАКЛЮЧЕНИЕ. Пациенты с глаукомой и миопией — часто встречающаяся категория лиц, которая требует тщательного динамического наблюдения и внимательного подхода в лечении. Молодой возраст дебюта глаукомы у таких пациентов и высокий риск инвалидизации обусловливает медико-социальную значимость проблемы и необходимость более детального исследования.</p></abstract><trans-abstract xml:lang="en"><p>PURPOSE. To study the opinions of ophthalmologists on the management strategy for patients with concurrent myopia and glaucoma.METHODS. This multicenter, scientific-analytical, descriptive, sample-based study was conducted by the "Scientific Vanguard" group of the Russian Glaucoma Society from July to September 2024 through an online survey of Russian ophthalmologists with varying experience, working in healthcare institutions of different ownership types. The developed questionnaire was hosted on a secure online platform. The study involved 302 ophthalmologists, with the overwhelming majority of clinicians (97%) working in the outpatient settings (89%) of state healthcare institutions (85%), with 6–15 years of work experience (48%), without a qualification category (44%), residing in large cities (41%) or cities with a population of over a million (44%).RESULTS. According to respondents, patients with combined glaucoma and myopia present weekly (48%). Moderate myopia was most common (58%), as well as younger age (70%), advanced stages of glaucoma (55%), moderately elevated intraocular pressure (IOP) (71%), and normaltension glaucoma (58%), which were characterized by rapid progression (52%), absence of complaints (72%), and concurrent cardiovascular conditions (44%). IOP was most often measured using the Maklakov tonometry method (47%). Diagnosing glaucoma in these patients was considered difficult (51%), and ophthalmologists preferred lower target IOP levels (83%), which were harder to achieve (53%). Respondents avoided prescribing m-cholinomimetics (33%) and β-blockers (27%), opting more often for combination therapy (75%). Nearly all believed that these patients require additional neuroprotective treatment (97%). Most respondents considered selective laser trabeculoplasty to be less effective (44%); such patients were operated on more frequently (51%) but with lower success rates (53%) and higher complication rates (60%).CONCLUSION. Glaucoma patients with myopia are frequently encountered and require careful long-term monitoring and personalized treatment strategies. The early onset of glaucoma and high risk of disability in this group underscore the medical and social significance of the problem and the need for a more detailed study.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>первичная открытоугольная глаукома</kwd><kwd>миопия</kwd><kwd>анкетирование врачей</kwd><kwd>глаукома низкого давления</kwd></kwd-group><kwd-group xml:lang="en"><kwd>primary open-angle glaucoma</kwd><kwd>myopia</kwd><kwd>questionnaires of doctors</kwd><kwd>low-pressure glaucoma</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Foster P.J., Jiang Y. Epidemiology of myopia. Eye (Lond) 2014; 28(2): 202-208. https://doi.org/10.1038/eye.2013.280.</mixed-citation><mixed-citation xml:lang="en">Foster P.J., Jiang Y. Epidemiology of myopia. Eye (Lond) 2014; 28(2): 202-208. https://doi.org/10.1038/eye.2013.280.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Holden B.A., Fricke T.R., Wilson D.A. et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology 2016; 123(5):1036-1042. https://doi.org/10.1016/j.ophtha.2016.01.006</mixed-citation><mixed-citation xml:lang="en">Holden B.A., Fricke T.R., Wilson D.A. et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology 2016; 123(5):1036-1042. https://doi.org/10.1016/j.ophtha.2016.01.006</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Allison K., Patel D., Alabi O. Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus 2020; 12(11):e11686. https://doi.org/10.7759/cureus.11686</mixed-citation><mixed-citation xml:lang="en">Allison K., Patel D., Alabi O. Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus 2020; 12(11):e11686. https://doi.org/10.7759/cureus.11686</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Knapp A. Glaucoma in Myopic Eyes. Trans Am Ophthalmol Soc 1925; 23:61-70.</mixed-citation><mixed-citation xml:lang="en">Knapp A. Glaucoma in Myopic Eyes. Trans Am Ophthalmol Soc 1925; 23:61-70.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell P., Hourihan F., Sandbach J., Wang J.J.. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology 1999; 106(10):2010-2015. https://doi.org/10.1016/s0161-6420(99)90416-5</mixed-citation><mixed-citation xml:lang="en">Mitchell P., Hourihan F., Sandbach J., Wang J.J.. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology 1999; 106(10):2010-2015. https://doi.org/10.1016/s0161-6420(99)90416-5</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wu J., Hao J., Du Y. et al. The Association between Myopia and Primary Open-Angle Glaucoma: A Systematic Review and Meta-Analysis. Ophthalmic Res 2022; 65(4):387-397. https://doi.org/10.1159/000520468</mixed-citation><mixed-citation xml:lang="en">Wu J., Hao J., Du Y. et al. The Association between Myopia and Primary Open-Angle Glaucoma: A Systematic Review and Meta-Analysis. Ophthalmic Res 2022; 65(4):387-397. https://doi.org/10.1159/000520468</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Xu L., Wang Y., Wang S. et al. High myopia and glaucoma susceptibility the Beijing Eye Study. Ophthalmology 2007; 114(2):216-220. https://doi.org/10.1016/j.ophtha.2006.06.050</mixed-citation><mixed-citation xml:lang="en">Xu L., Wang Y., Wang S. et al. High myopia and glaucoma susceptibility the Beijing Eye Study. Ophthalmology 2007; 114(2):216-220. https://doi.org/10.1016/j.ophtha.2006.06.050</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chen H.S., Liu C.H., Lu D.W. Comparison of glaucoma diagnostic accuracy of macular ganglion cell complex thickness based on nonhighly myopic and highly myopic normative database. Taiwan J Ophthalmol 2016; 6(1):15-20. https://doi.org/10.1016/j.tjo.2016.01.001</mixed-citation><mixed-citation xml:lang="en">Chen H.S., Liu C.H., Lu D.W. Comparison of glaucoma diagnostic accuracy of macular ganglion cell complex thickness based on nonhighly myopic and highly myopic normative database. Taiwan J Ophthalmol 2016; 6(1):15-20. https://doi.org/10.1016/j.tjo.2016.01.001</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rolle T., Bonetti B., Mazzucco A., Dallorto L. Diagnostic ability of OCT parameters and retinal ganglion cells count in identification of glaucoma in myopic preperimetric eyes. BMC Ophthalmol 2020; 20(1):373. https://doi.org/10.1186/s12886-020-01616-5</mixed-citation><mixed-citation xml:lang="en">Rolle T., Bonetti B., Mazzucco A., Dallorto L. Diagnostic ability of OCT parameters and retinal ganglion cells count in identification of glaucoma in myopic preperimetric eyes. BMC Ophthalmol 2020; 20(1):373. https://doi.org/10.1186/s12886-020-01616-5</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lin F.B., Da Chen S., Song Y.H. et al. Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial. Trials 2020; 21(1):813. https://doi.org/10.1186/s13063-020-04748-7</mixed-citation><mixed-citation xml:lang="en">Lin F.B., Da Chen S., Song Y.H. et al. Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial. Trials 2020; 21(1):813. https://doi.org/10.1186/s13063-020-04748-7</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshida T., Yoshimoto S., Nomura T. et al. Intraocular pressure-lowering effects of ripasudil on open-angle glaucoma in eyes with high myopia and pathological myopia. Sci Rep 2023; 13(1):22888. https://doi.org/10.1038/s41598-023-49782-y</mixed-citation><mixed-citation xml:lang="en">Yoshida T., Yoshimoto S., Nomura T. et al. Intraocular pressure-lowering effects of ripasudil on open-angle glaucoma in eyes with high myopia and pathological myopia. Sci Rep 2023; 13(1):22888. https://doi.org/10.1038/s41598-023-49782-y</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Казакова А.В., Эскина Э.Н. Диагностика глаукомы у пациентов с близорукостью. Национальный журнал Глаукома 2015; 14(3):87-100.</mixed-citation><mixed-citation xml:lang="en">Kazakova A.V., Eskina E.N. Glaucoma diagnostics in myopic patients. National Journal Glaucoma 2015; 14(3):87-100.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Жукова С.И., Юрьева Т.Н., Помкина И.В., Грищук А.С. Оценка с помощью оптической когерентной томографии бета-зоны перипапиллярной атрофии как биомаркера глаукомы, ассоциированной с миопией. Сибирский научный медицинский журнал 2019; 39(3):45-49. https://doi.org/10.15372/SSMJ20190307</mixed-citation><mixed-citation xml:lang="en">Zhukova S.I., Yur’yeva T.N., Pomkina I.V., Grishchuk A.S. Beta zone of peripapillary atrophy by optical coherence tomography as a biomarker of glaucoma associated with myopia. Siberian Scientific Medical Journal 2019; 39(3):45-49. https://doi.org/10.15372/SSMJ20190307</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Зверева О.Г., Ляхова Е.А., Селезнев А.В. и соавт. Дифференциально-диагностические признаки начальной глаукомы у пациентов с миопией высокой степени. Национальный журнал Глаукома 2020; 19(4):64-72. https://doi.org/10.25700/NJG.2020.04.08</mixed-citation><mixed-citation xml:lang="en">Zvereva O.G., Lyakhova E.A., Seleznev A.V., Gazizova I.R., Brezhnev A.Yu., Kuroyedov A.V. Differential diagnostic signs of glaucoma in patients with high myopia. National Journal Glaucoma 2020; 19(4):64-72. https://doi.org/10.25700/NJG.2020.04.08</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Нероев В.В. Состояние Российской офтальмологической службы в свете проблем системы здравоохранения. Москва, РООФ 2014. https://helmholtzeyeinstitute.ru/photo/9-30-Doklad-NeroevVVotkrytie.pdf (Дата обращения: 10.12.2021)</mixed-citation><mixed-citation xml:lang="en">Neroev V.V. Condition of Russian ophthalmology service as an aspect of the healthcare system issues. Moscow, Russian National Ophthalmology Forum, 2014. https://helmholtzeyeinstitute.ru/photo/9-30-Doklad-Neroev-VVotkrytie.pdf (Access date: 10.12.2021)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Chihara E., Sawada A. Atypical Nerve Fiber Layer Defects in High Myopes With High-Tension Glaucoma. Arch Ophthalmol 1990; 108(2): 228-232. https://doi.org/10.1001/archopht.1990.01070040080035</mixed-citation><mixed-citation xml:lang="en">Chihara E., Sawada A. Atypical Nerve Fiber Layer Defects in High Myopes With High-Tension Glaucoma. Arch Ophthalmol 1990; 108(2): 228-232. https://doi.org/10.1001/archopht.1990.01070040080035</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Акопян А.И. Дифференциально-диагностические критерии изменений диска зрительного нерва при глаукоме и миопии. Дисс. канд. мед. наук. М: 2008; 153.</mixed-citation><mixed-citation xml:lang="en">Akopyan A.I. Differential diagnostic criteria for changes of the optic nerve in glaucoma and myopia. Diss. (Cand. Med. Sci.). Moscow, 2008: 153 p.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">David R., Zangwill L.M., Tessler Z., Yassur Y. The Correlation between Intraocular Pressure and Refractive Status. Arch Ophthalmol 1985, 103:1812-1815.</mixed-citation><mixed-citation xml:lang="en">David R., Zangwill L.M., Tessler Z., Yassur Y. The Correlation between Intraocular Pressure and Refractive Status. Arch Ophthalmol 1985, 103:1812-1815.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Y., Li Z., Wang N. et al. Intraocular Pressure Fluctuation in Patients with Primary Open-Angle Glaucoma Combined with High Myopia. J Glaucoma 2014; 23(1):19-22. https://doi.org/10.1097/IJG.0b013e31825afc9d.</mixed-citation><mixed-citation xml:lang="en">Yang Y., Li Z., Wang N. et al. Intraocular Pressure Fluctuation in Patients with Primary Open-Angle Glaucoma Combined with High Myopia. J Glaucoma 2014; 23(1):19-22. https://doi.org/10.1097/IJG.0b013e31825afc9d.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Guo Z.Z., Chang K., Wei X. Intraocular pressure fluctuation and the risk of glaucomatous damage deterioration: a Meta-analysis. Int J Ophthalmol 2019; 12(1):123-128. https://doi.org/10.18240/ijo.2019.01.19</mixed-citation><mixed-citation xml:lang="en">Guo Z.Z., Chang K., Wei X. Intraocular pressure fluctuation and the risk of glaucomatous damage deterioration: a Meta-analysis. Int J Ophthalmol 2019; 12(1):123-128. https://doi.org/10.18240/ijo.2019.01.19</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Patel A., Patel D., Prajapati V. et al. A Study on the Association Between Myopia and Elevated Intraocular Pressure Conducted at a Tertiary Care Teaching Hospital in Gujarat, India. Cureus 2022; 14(8):e28128. https://doi.org/10.7759/cureus.28128</mixed-citation><mixed-citation xml:lang="en">Patel A., Patel D., Prajapati V. et al. A Study on the Association Between Myopia and Elevated Intraocular Pressure Conducted at a Tertiary Care Teaching Hospital in Gujarat, India. Cureus 2022; 14(8):e28128. https://doi.org/10.7759/cureus.28128</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Detry-Morel M. Is myopia a risk factor for glaucoma? J Fr Ophtalmol 2011; 34(6):392-395 https://doi.org/10.1016/j.jfo.2011.03.009.</mixed-citation><mixed-citation xml:lang="en">Detry-Morel M. Is myopia a risk factor for glaucoma? J Fr Ophtalmol 2011; 34(6):392-395 https://doi.org/10.1016/j.jfo.2011.03.009.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Еричев В.П., Петров С.Ю., Волжанин А.В. и соавт. Альфа-адреномиметики в контексте современных представлений о мониторинге и лечении глаукомы. Клиническая офтальмология. 2019; 19(2):87-91. https://doi.org/10.32364/2311-7729-2019-19-2-87-91.</mixed-citation><mixed-citation xml:lang="en">Erichev V.P., Petrov S.Yu., Volzhanin A.V. et al. Alpha-adrenergic receptor agonists in terms of modern views on glaucoma monitoring and treatment. Clinical Ophthalmology 2019; 19(2):87-91. https://doi.org/10.32364/2311-7729-2019-19-2-87-91</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Cantor L.B. Brimonidine in the treatment of glaucoma and ocular hypertension. Ther Clin Risk Manag 2006; 2(4):337-346. https://doi.org/10.2147/tcrm.2006.2.4.337</mixed-citation><mixed-citation xml:lang="en">Cantor L.B. Brimonidine in the treatment of glaucoma and ocular hypertension. Ther Clin Risk Manag 2006; 2(4):337-346. https://doi.org/10.2147/tcrm.2006.2.4.337</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Nitta K., Shimamoto S., Wajima R. et al. The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients. Clin Ophthalmol 2020; 14:213-219. https://doi.org/10.2147/OPTH.S237969</mixed-citation><mixed-citation xml:lang="en">Nitta K., Shimamoto S., Wajima R. et al. The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients. Clin Ophthalmol 2020; 14:213-219. https://doi.org/10.2147/OPTH.S237969</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt K-G., Ruckmann A., Pullinat L.E. Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma. Br J Ophthalmol 1998; 82:758-762. https://doi.org/10.1136/bjo.82.7.758.</mixed-citation><mixed-citation xml:lang="en">Schmidt K-G., Ruckmann A., Pullinat L.E. Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma. Br J Ophthalmol 1998; 82:758-762. https://doi.org/10.1136/bjo.82.7.758.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Martínez A., Sanchez-Salorio M. Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma. Acta Ophthalmol 2010; 88(5):541-552. https://doi.org/10.1111/j.1755-3768.2009.01595.x</mixed-citation><mixed-citation xml:lang="en">Martínez A., Sanchez-Salorio M. Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma. Acta Ophthalmol 2010; 88(5):541-552. https://doi.org/10.1111/j.1755-3768.2009.01595.x</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Siesky B., Harris A., Kagemann L. et al. Ocular blood flow and oxygen delivery to the retina in primary open-angle glaucoma patients: the addition of dorzolamide to timolol monotherapy. Acta Ophthalmol 2010; 88(1):142-149. https://doi.org/10.1111/j.1755-3768.2009.01604.x</mixed-citation><mixed-citation xml:lang="en">Siesky B., Harris A., Kagemann L. et al. Ocular blood flow and oxygen delivery to the retina in primary open-angle glaucoma patients: the addition of dorzolamide to timolol monotherapy. Acta Ophthalmol 2010; 88(1):142-149. https://doi.org/10.1111/j.1755-3768.2009.01604.x</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Нагорнова З.М., Куроедов А.В., Селезнев А.В. Сравнительный анализ эффективности и безопасности применения фиксированных комбинаций и их отдельных компонентов в лечении пациентов с первичной открытоугольной глаукомой. РМЖ Клиническая офтальмология 2019; 19(1):13-19. https://doi.org/10.21689/2311-7729-2019-19-1-13-19</mixed-citation><mixed-citation xml:lang="en">Nagornova Z.M., Kuroyedov A.V., Seleznev A.V. Comparative analysis of the efficacy and safety of fixed-dose combinations versus their individual components for open-angle glaucoma. RMJ Clinical Ophthalmology 2019; 19(1):13-19. https://doi.org/10.21689/2311-7729-2019-19-1-13-19</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Jonas J.D., Panda-Jonas S., Ohno-Matsui K. Glaucoma in High Myopia (in Updates on Myopia. A Clinical Perspective (eds. Ang M., Wong T.Y.). Singapore, Springer, 2020:306. https://doi.org/10.1007/978-981-13-8491-2_11</mixed-citation><mixed-citation xml:lang="en">Jonas J.D., Panda-Jonas S., Ohno-Matsui K. Glaucoma in High Myopia (in Updates on Myopia. A Clinical Perspective (eds. Ang M., Wong T.Y.). Singapore, Springer, 2020:306. https://doi.org/10.1007/978-981-13-8491-2_11</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
